Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
about
B cells responses and cytokine production are regulated by their immune microenvironmentCurrent Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.
P2860
Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
@en
type
label
Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
@en
prefLabel
Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
@en
P2093
P2860
P1476
Targeting B cells and autoantibodies in the therapy of autoimmune diseases.
@en
P2093
Daniela Kao
Inessa Schwab
P2860
P2888
P304
P356
10.1007/S00281-014-0427-7
P577
2014-04-29T00:00:00Z
P6179
1025605175